好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Exposure-Response Analysis of Eslicarbazepine Acetate Adjunctive Treatment of Patients with Partial-Onset Seizures
Epilepsy
(-)
215
Authors/Disclosures
Gary Maier, PhD (Sunovion Pharmaceuticals Inc.) No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.) No disclosure on file
No disclosure on file
Sameer Ansari Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Sameer Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIcrovention. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Imperative Care. Sameer Ansari has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculus Imaging. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfuze. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Sameer Ansari has or had stock in Clearvoya LLC. An immediate family member of Sameer Ansari has or had stock in Hyperfine. The institution of Sameer Ansari has received research support from NIH. Sameer Ansari has received intellectual property interests from a discovery or technology relating to health care.
Jahnavi Kharidia, PhD, RPh, RAC (Sunovion Pharmaceuticals Inc.) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file